Clinical Trial Update: Treatment of Moderate to Severe Glabellar Lines (BMI2006) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for BMI2006 treating moderate to severe glabellar lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Lines

Drugs mentioned

• BMI2006

Snippet

Sponsor: BMI Korea | Conditions: Glabellar Lines | Phase 3 | Status: COMPLETED